ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,797,000 | -7.4% | 466,015 | +1.9% | 4.62% | +89.0% |
| Q3 2016 | $6,262,000 | +96.7% | 457,415 | +6.2% | 2.44% | +79.0% |
| Q2 2016 | $3,184,000 | -12.4% | 430,890 | -25.9% | 1.37% | +151.1% |
| Q4 2015 | $3,633,000 | -2.0% | 581,215 | -8.4% | 0.54% | -78.6% |
| Q3 2015 | $3,707,000 | -36.5% | 634,772 | -10.0% | 2.54% | +49.6% |
| Q2 2015 | $5,835,000 | -21.3% | 705,580 | -21.6% | 1.70% | -37.5% |
| Q1 2015 | $7,416,000 | +34.9% | 900,000 | +12.5% | 2.72% | +5.4% |
| Q4 2014 | $5,496,000 | +45.4% | 800,000 | +14.3% | 2.58% | +36.9% |
| Q3 2014 | $3,780,000 | +31.8% | 700,000 | +55.6% | 1.88% | -4.6% |
| Q2 2014 | $2,867,000 | -45.1% | 450,000 | -30.6% | 1.97% | -47.2% |
| Q1 2014 | $5,223,000 | -36.2% | 648,000 | -46.0% | 3.74% | +175.6% |
| Q4 2013 | $8,184,000 | – | 1,200,000 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |